0 new0 added0 reduced51 sold outnet sold ≈ $125.3m (-13.6m shares)
* Summed across managers. Shares that two managers' reports both contain – a
subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are
counted once.
Holder counts are more reliable.
Implied quarter-end price ≈ $10.27.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
Quarter
Holders
Q3 2022
54
Q4 2022
61
Q1 2023
60
Q2 2023
64
Q3 2023
55
Q4 2023
54
Q1 2024
51
Q2 2024
64
Q3 2024
48
Q4 2024
66
Q1 2025
54
Q2 2025
2
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D
if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the
stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder
worked them out.
Holder
Stake
Change
Shares
Last filed
GENTEX CORP
13D · may seek influencefiled 2024-12-18Stated purposeMERGER AGREEMENT
On December 17, 2024, Gentex and Merger Sub entered into an Agreement and Plan of Merger (the "Merger Agreement") with the Issuer.
MERGER
On the terms and subject to the conditions of the Merger Agreement, Merger Sub will merge with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Gentex.
MERGER CONSIDERATION
The Merger Agreement provides that, upon completion of the Merger, each share of Class A common stock and Class B common Stock of the Issuer (other than dissenting shares and common stock of the Issuer owned by a Gentex, Merger Sub or the Issuer, or any subsidiary thereof to be cancelled in accordance with the Merger Agreement) will be converted into the right to receive $7.50 in cash, witho…
Full filing